In a filing, Hologic, Inc. revealed its Director GARRETT SCOTT T unloaded Company’s shares for reported $1.24 million on Mar 14 ’24. In the deal valued at $75.50 per share,16,441 shares were sold. As a result of this transaction, GARRETT SCOTT T now holds 48,611 shares worth roughly $3.77 million.
Then, CRAWFORD SALLY sold 9,039 shares, generating $690,607 in total proceeds. Upon selling the shares at $76.40, the Director now owns 132,927 shares.
Before that, Dockendorff Charles J sold 1,465 shares. Hologic, Inc. shares valued at $111,648 were divested by the Director at a price of $76.21 per share. As a result of the transaction, Dockendorff Charles J now holds 1,572 shares, worth roughly $0.12 million.
Citigroup upgraded its Hologic, Inc. [HOLX] rating to a Buy from a a Neutral in a research note published on April 03, 2024; the price target was increased to $95 from $80. A number of analysts have revised their coverage, including Needham’s analysts, who increased its forecast for the stock in mid July from “a Hold” to “a Buy”. RBC Capital Mkts began covering HOLX with “Sector perform” recommendation on December 07, 2022. Mizuho started covering the stock on October 13, 2022. It rated HOLX as “a Buy”.
Price Performance Review of HOLX
On Monday, Hologic, Inc. [NASDAQ:HOLX] saw its stock jump 0.27% to $77.54. Over the last five days, the stock has gained 0.21%. Hologic, Inc. shares have risen nearly 8.52% since the year began. Nevertheless, the stocks have fallen -8.69% over the past one year. While a 52-week high of $87.88 was reached on 04/04/24, a 52-week low of $64.02 was recorded on 01/02/24. SMA at 50 days reached $75.49, while 200 days put it at $73.49. A total of 1.61 million shares were traded, compared to the trading of 1.57 million shares in the previous session.
Levels Of Support And Resistance For HOLX Stock
The 24-hour chart illustrates a support level at 77.08, which if violated will result in even more drops to 76.63. On the upside, there is a resistance level at 78.17. A further resistance level may holdings at 78.81. The Relative Strength Index (RSI) on the 14-day chart is 55.49, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.23, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 42.00%. Stochastics %K at 59.84% indicates the stock is a holding.
The most recent change occurred on July 20, 2022 when UBS began covering the stock and recommended ‘”a Neutral”‘ rating along with a $73 price target.
